Glyoxal-induced formation of advanced glycation end-products in type 1 collagen decreases both its strength and flexibility in vitro

J Diabetes Investig. 2021 Sep;12(9):1555-1559. doi: 10.1111/jdi.13528. Epub 2021 Mar 11.

Abstract

The high plasma glucose induced in glucose metabolism disorders leads to the non-enzymatic glucose-dependent modification (glycation) of type 1 collagen, which is an essential component of bone tissue. The glycation of proteins induces the formation of advanced glycation end-products, such as carboxymethyl arginine, which is preferentially generated in glycated collagen. However, the effect of advanced glycation end-product formation on the characteristics of type 1 collagen remains unclear due to the lack of suitable in vitro experimental systems analyzing type 1 collagen. Here, we show that the glycation of type 1 collagen can be analyzed in vitro using a goldfish-scale bone model. Our study using these scales provides evidence that the advanced glycation end-product formation in type 1 collagen induced by glyoxal, the carboxymethyl arginine inducer, facilitates the crosslinking of type 1 collagen, decreasing both its strength and flexibility.

Keywords: Carboxymethyl arginine; Fish scales; Type 1 collagen.

MeSH terms

  • Animals
  • Bone and Bones / drug effects
  • Bone and Bones / metabolism
  • Bone and Bones / pathology*
  • Collagen Type I / metabolism*
  • Glycation End Products, Advanced / drug effects
  • Glycation End Products, Advanced / metabolism*
  • Glyoxal / pharmacology*
  • Goldfish

Substances

  • Collagen Type I
  • Glycation End Products, Advanced
  • Glyoxal